Literature DB >> 9426907

A new silver sulfadiazine water soluble gel.

A J Gear1, T B Hellewell, H R Wright, P M Mazzarese, P B Arnold, G T Rodeheaver, R F Edlich.   

Abstract

Silver sulfadiazine is the most commonly used topical antibacterial agent for the treatment of burn wounds. It has many clinical advantages, including a broad spectrum of antimicrobial activity, low toxicity, and minimal pain on application. The current formulation of silver sulfadiazine contains a lipid soluble carrier, polypropylene glycol, that has certain disadvantages, including pseudo-eschar formation and the need for twice daily application. The purpose of this investigation was to describe a new formulation of silver sulfadiazine in a water soluble gel, poloxamer 188. The antibacterial activity of this new gel has been compared to that of the commercially available silver sulfadiazine cream by in vitro and in vivo testing. The results of the in vitro antibacterial testing of these two different agents demonstrated the superiority of the new gel formulation. In experimental wounds, the antibacterial activity of the gel and the commercially available silver sulfadiazine cream were not significantly different when applied once a day. The antibacterial activity of the gel when applied once a day was comparable to that encountered by twice daily applications of the silver sulfadiazine cream by experimental wounds. The major advantage of this gel was its ease of application and removal that is attributed to its water solubility.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9426907     DOI: 10.1016/s0305-4179(97)89763-x

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  3 in total

Review 1.  A general overview of burn care.

Authors:  Michel H E Hermans
Journal:  Int Wound J       Date:  2005-09       Impact factor: 3.315

2.  In vitro and murine efficacy and toxicity studies of nebulized SCC1, a methylated caffeine-silver(I) complex, for treatment of pulmonary infections.

Authors:  Carolyn L Cannon; Lisa A Hogue; Ravy K Vajravelu; George H Capps; Aida Ibricevic; Khadijah M Hindi; Aysegul Kascatan-Nebioglu; Michael J Walter; Steven L Brody; Wiley J Youngs
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

3.  Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns.

Authors:  Vaishali Thakkar; Vaishali Korat; Lalji Baldaniya; Mukesh Gohel; Tejal Gandhi; Nirav Patel
Journal:  Int J Pharm Investig       Date:  2016 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.